Rapamycin In Angiomyolipomas In Patients With Tuberous Sclerosis
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether rapamycin is safe and effective in the
treatment of renal angiomyolipomas in patients with tuberousclerosis.